flutiform 1255
rafa laboratories ltd - fluticasone propionate; formoterol fumarate dihydrate - pressurised suspention for inhalation - fluticasone propionate 0.125 mg/dose; formoterol fumarate dihydrate 0.005 mg/dose - fluticasone - fluticasone - the regular treatment of asthma where use of a combination product (an inhaled corticosteroid and a long -acting β2 agonist) is appropriate:• for patients not adequately controlled with inhaled corticosteroids and ‘as required’ inhaled short -acting β2 agonist.• for patients already adequately controlled on both an inhaled corticosteroid and a long-acting β2 agonist.flutiform 125mcg/5mcg inhaler is indicated in adults and adolescents aged 12 years and above.
flutiform 25010
rafa laboratories ltd - fluticasone propionate; formoterol fumarate dihydrate - pressurised suspention for inhalation - fluticasone propionate 0.25 mg/dose; formoterol fumarate dihydrate 0.01 mg/dose - fluticasone - fluticasone - the regular treatment of asthma where use of a combination product (an inhaled corticosteroid and a long -acting β2 agonist) is appropriate:• for patients not adequately controlled with inhaled corticosteroids and ‘as required’ inhaled short -acting β2 agonist.• for patients already adequately controlled on both an inhaled corticosteroid and a long-acting β2 agonist.flutiform 250mcg/10mcg inhaler is indicated in adults only.
flutiform 50 microgram5 microgram per actuation pressurised inhalation suspension
mundipharma pharmaceuticals sdn. bhd. - fluticasone propionate; formoterol fumarate -
flutiform 125 microgram5 microgram per actuation pressurised inhalation suspension
mundipharma pharmaceuticals sdn. bhd. - fluticasone propionate; formoterol fumarate -
flutiform 250 microgram10 microgram per actuation pressurised inhalation suspension
mundipharma pharmaceuticals sdn. bhd. - fluticasone propionate; formoterol fumarate -
flutiform 50 µg - 5 µg press. inhal. susp. press. cont.
mundipharma bv-srl - fluticasone propionate 0,05 mg; sodium cromoglicate 0,024 mg; formoterol fumarate dihydrate 0,005 mg - pressurised inhalation, suspension - 50 µg - 5 µg - fluticasone propionate 0.05 mg; formoterol fumarate dihydrate 5 µg - formoterol and fluticasone
flutiform 125 µg - 5 µg press. inhal. susp. press. cont.
mundipharma bv-srl - fluticasone propionate 0,125 mg; sodium cromoglicate 0,024 mg; formoterol fumarate dihydrate 0,005 mg - pressurised inhalation, suspension - 125 µg - 5 µg - fluticasone propionate 125 µg; formoterol fumarate dihydrate 5 µg - formoterol and fluticasone
flutiform 250 µg - 10 µg press. inhal. susp. press. cont.
mundipharma bv-srl - formoterol fumarate dihydrate 0,01 mg; fluticasone propionate 0,25 mg - pressurised inhalation, suspension - 250 µg - 10 µg - fluticasone propionate 0.25 mg; formoterol fumarate dihydrate 0.01 mg - formoterol and fluticasone
flutiform k-haler 125 µg/dose - 5 µg/dose press. inhal. susp. inhaler
mundipharma bv-srl - fluticasone propionate 0,125 mg/dose; formoterol fumarate dihydrate 0,005 mg/dose - pressurised inhalation, suspension - 125 µg/dose - 5 µg/dose - fluticasone propionate 0.125 mg/dose; formoterol fumarate dihydrate 0.005 mg/dose - formoterol and fluticasone
flutiform k-haler 50 µg/dose - 5 µg/dose press. inhal. susp. inhaler
mundipharma bv-srl - fluticasone propionate 0,05 mg/dose; formoterol fumarate dihydrate 0,005 mg/dose - pressurised inhalation, suspension - 50 µg/dose - 5 µg/dose - fluticasone propionate 0.05 mg/dose; formoterol fumarate dihydrate 0.005 mg/dose - formoterol and fluticasone